Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Stratton

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Fibrogenesis & Tissue Repair|June 4, 2011
Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissuesLuke Morgan-Rowe, Joanna Nikitorowicz, Xu Shiwen, et al.
Rheumatology (Oxford, England)|November 22, 2018
Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosisJohn Henderson, Max Brown, Steven Horsburgh, et al.
Cells|August 27, 2021
The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic SclerosisJohn Henderson, Sharadha Dayalan Naidu, Albena T Dinkova-Kostova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 9, 2002
Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathwayRichard Stratton, Vineeth Rajkumar, Markella Ponticos, et al.
International Journal of Nanomedicine|February 1, 2017
Quantitative nanohistological investigation of scleroderma: an atomic force microscopy-based approach to disease characterizationAdam P Strange, Sebastian Aguayo, Tarek Ahmed, et al.
BMC Infectious Diseases|April 20, 2021
COVID-19 in Northeast Bosnia and Herzegovina and patient's length of hospitalizationAlma Trnacevic, Amer Mujkanovic, Noura Al-Salloum, et al.
Frontiers in Cell and Developmental Biology|June 21, 2021
Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic SclerosisLaura Duffy, John Henderson, Max Brown, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 3, 2008
A clinical electrophysiological study of emotional lability in patients with systemic lupus erythematosusJens Langosch, Stacey Rand, Boyd Ghosh, et al.
Cells|October 27, 2023
Autoantibodies Which Bind to and Activate Keratinocytes in Systemic SclerosisCarine Moezinia, Valerie Wong, James Watson, et al.
Radiation Oncology (London, England)|June 3, 2014
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapyCharlotte B Westbury, Joanne Haviland, Sue Davies, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Fibrogenesis & Tissue Repair|June 4, 2011
Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissuesLuke Morgan-Rowe, Joanna Nikitorowicz, Xu Shiwen, et al.
Rheumatology (Oxford, England)|November 22, 2018
Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosisJohn Henderson, Max Brown, Steven Horsburgh, et al.
Cells|August 27, 2021
The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic SclerosisJohn Henderson, Sharadha Dayalan Naidu, Albena T Dinkova-Kostova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 9, 2002
Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathwayRichard Stratton, Vineeth Rajkumar, Markella Ponticos, et al.
International Journal of Nanomedicine|February 1, 2017
Quantitative nanohistological investigation of scleroderma: an atomic force microscopy-based approach to disease characterizationAdam P Strange, Sebastian Aguayo, Tarek Ahmed, et al.
BMC Infectious Diseases|April 20, 2021
COVID-19 in Northeast Bosnia and Herzegovina and patient's length of hospitalizationAlma Trnacevic, Amer Mujkanovic, Noura Al-Salloum, et al.
Frontiers in Cell and Developmental Biology|June 21, 2021
Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic SclerosisLaura Duffy, John Henderson, Max Brown, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 3, 2008
A clinical electrophysiological study of emotional lability in patients with systemic lupus erythematosusJens Langosch, Stacey Rand, Boyd Ghosh, et al.
Cells|October 27, 2023
Autoantibodies Which Bind to and Activate Keratinocytes in Systemic SclerosisCarine Moezinia, Valerie Wong, James Watson, et al.
Radiation Oncology (London, England)|June 3, 2014
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapyCharlotte B Westbury, Joanne Haviland, Sue Davies, et al.
Pageof 6